German biopharmaceutical firm BioNTech has partnered with Genevant Sciences, a genetic disorder therapeutics maker, to develop mRNA therapy programmes, which target rare diseases with high unmet medical need. As part of the alliance, the companies […]
AbbVie has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration for the use of its venetoclax drug to treat acute myeloid leukaemia , an aggressive blood cancer. The application […]
California-based drug delivery and development company Cure Pharmaceuticals has signed an agreement to acquire Israeli cannabinoid-focused company Therapix Biosciences’ non-pain assets. In payment Cure will issue common shares to Therapix. making it a significant shareholder, […]
The US Food and Drug Administration (FDA) has ordered changes to safety labelling of the fluoroquinolone antibiotics class to include associated mental health side effects and serious blood sugar disturbances. The regulatory agency requires these […]
SMi Reports: An exclusive interview with Dr Michel Mikhail, an independent consultant and chairman of this year’s Biosimilars &Biobetters conference, is now available to download on the event website. SMi Grouprecently caught up with expert […]